Encision completes private placement of stock
BOULDER — Encision Inc., a medical device company that has developed technology to prevent stray electrosurgical burns, completed a private placement of 875,000 shares of its common stock.
The private placement to CMED Partners LLLP represents 7.6 percent of the total number of shares. It will raise a total of $350,000 or 40 cents per share, before costs.
“We appreciate the continued confidence that CMED has placed in us,” Greg Trudel, resident and CEO of Encision, said in a prepared statement. “Net proceeds from the sale of the shares will be used for general business purposes and, in particular, for greater sales, marketing, and research and development presence.”
SPONSORED CONTENT
People Powered: Preparing Longmont Businesses for Economic Success
Longmont Chamber and FNBO present People Powered on April 24, 2024, aiming to inform business owners about workforce development, housing, and transportation issues.
The securities were offered only to CMED, an accredited investor.
BOULDER — Encision Inc., a medical device company that has developed technology to prevent stray electrosurgical burns, completed a private placement of 875,000 shares of its common stock.
The private placement to CMED Partners LLLP represents 7.6 percent of the total number of shares. It will raise a total of $350,000 or 40 cents per share, before costs.
“We appreciate the continued confidence that CMED has placed in us,” Greg Trudel, resident and CEO of Encision, said in a prepared statement. “Net proceeds from the sale of the shares will be used for general business…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!